Celgene reported 92 mil in quarterly Vidaza sales a 52% year over year increase. ( If was us we'd be at at 15 to 20 bucks a share .)
Anyway headline states gain form increased market share and duration of use. Need to hear conference call to see if we can determine how it effected Dacogen. It will be an interesting day for our little SUPG. If we're up it will be truly a wonderous thing.